Caremax Inc (CMAX) Return on Equity ROE from the second quarter 2024 to second quarter 2023 and annually, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket
 


Caremax Inc   (NASDAQ: CMAX)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Caremax Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Caremax Inc in the second quarter 2024?
Due to the lack of equity, it was not possible to calculate Caremax Inc 's return on equity (ROE) in its second quarter 2024

What is ROE?




Return On Equity (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -783 -645 -683 -207 -126
Return On Equity (TTM) - -12638.81 % - - -107.48 %
CMAX's Total Ranking # # # # #
Equity (TTM) in Millions -148 20 0 0 0
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





CMAX Annual Return On Equity (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020

Total Equity in Millions 0 0 505 5 0
Y / Y Equity Change - - 10007.38 % - -
Net Income in Millions -683 -38 -7 -22 0
Y / Y Net Income Change - - - - -
Return On Equity - - -1.32 % -430.21 % -





More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CMAX's' Return on Equity at Yahoo Finance
CMAX's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CMAX's Competitors
Subscribers only: Roe for Caremax Inc 's Suppliers
Subscribers only: Return On Equity for CMAX's Customers




Companies with similar Return On Equity at Jun 30 2024, within Healthcare Sector ROE
Inhibrx Biosciences Inc   1,617.60 %
Glucotrack Inc   825.27 %
Ir med Inc   749.30 %
Hca Healthcare Inc   658.22 %
Longduoduo Co Ltd  652.11 %


Date modified: 2026-09-08T15:11:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.